© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 38212 refers to the procedure of transplant preparation of hematopoietic progenitor cells, specifically focusing on the removal of red blood cells from the harvested collection. Hematopoietic progenitor cells are essential components in the process of stem cell transplantation, as they have the potential to develop into various types of blood cells. This procedure is crucial for ensuring that the cells used in transplantation are free from unwanted components, such as red blood cells, which can complicate the infusion process and affect patient outcomes. The harvested cells are typically preserved using a cryoprotectant solution and stored at low temperatures to maintain their viability until they are needed for infusion. When preparing these cells for transplantation, it is important to follow specific coding guidelines to accurately reflect the procedure performed. For instance, if the procedure involves the separation of specific tumor cells to prevent the reinfusion of the patient's own diseased cells, CPT® Code 38211 should be used. Conversely, if the focus is on the removal of red blood cells, as indicated by Code 38212, this code should be applied. Additionally, if platelets are removed from the harvested collection, CPT® Code 38213 would be appropriate. Understanding these distinctions is vital for accurate medical coding and billing in the context of hematopoietic cell transplantation.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.